IDEXX Laboratories (IDXX) Stock Analysis & AI Equity Report

Medical - Equipment & Services USD Explore free reports

IDEXX Laboratories (IDXX) overview

IDEXX Laboratories (IDXX) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 4,304m and operating profit of USD 1,360m; the year-end share price was 676.53 USD and market capitalisation was USD 53,928m. IDEXX Laboratories is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get IDEXX Laboratories's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,605mFY 2025
Share price676.53 USDFY 2025 year end
RevenueUSD 4,304mFY 2025
Operating profitUSD 1,360mFY 2025
Net earningsUSD 1,059mFY 2025
Market capitalisationUSD 53,928mFY 2025 year end

About IDEXX Laboratories

IDEXX Laboratories develops, manufactures, and distributes products and services for companion animal veterinary, livestock, poultry and dairy, and water testing industries. Its offerings include veterinary diagnostic instruments, consumables and rapid tests; reference laboratory and consulting services; practice management software and imaging systems; livestock health monitoring products; and water testing products. It also provides human medical point-of-care diagnostic products and serves the biomedical research community.

Generate the IDEXX Laboratories report

IDEXX Laboratories is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for IDEXX Laboratories and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on IDEXX Laboratories

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.